BSE Live
Oct 01, 10:44Prev. Close
728.60
Open Price
720.20
Bid Price (Qty.)
730.90 (26)
Offer Price (Qty.)
732.75 (1)
NSE Live
Oct 01, 10:44Prev. Close
729.05
Open Price
729.90
Bid Price (Qty.)
731.55 (1)
Offer Price (Qty.)
732.20 (28)
Profit & Loss account of Supriya Lifescience (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | |
12 mths | 12 mths | 12 mths | 12 mths | ||
INCOME | |||||
Revenue From Operations [Gross] | 696.49 | 634.03 | 506.55 | 530.05 | |
Less: Excise/Sevice Tax/Other Levies | 0.00 | 76.59 | 55.53 | 0.00 | |
Revenue From Operations [Net] | 696.49 | 557.44 | 451.01 | 530.05 | |
Total Operating Revenues | 696.49 | 570.37 | 460.94 | 530.05 | |
Other Income | 9.82 | 10.64 | 9.49 | 7.58 | |
Total Revenue | 706.30 | 581.01 | 470.43 | 537.63 | |
EXPENSES | |||||
Cost Of Materials Consumed | 232.44 | 191.43 | 187.32 | 198.83 | |
Purchase Of Stock-In Trade | 0.00 | 0.00 | 0.00 | 0.00 | |
Operating And Direct Expenses | 0.00 | 0.00 | 0.00 | 0.00 | |
Changes In Inventories Of FG,WIP And Stock-In Trade | -21.26 | 30.31 | -6.51 | -3.03 | |
Employee Benefit Expenses | 80.52 | 67.64 | 55.58 | 49.08 | |
Finance Costs | 1.69 | 2.11 | 3.08 | 4.20 | |
Depreciation And Amortisation Expenses | 20.44 | 15.81 | 11.82 | 10.12 | |
Other Expenses | 143.99 | 108.02 | 95.65 | 71.18 | |
Total Expenses | 457.82 | 415.32 | 346.94 | 330.38 | |
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 248.48 | 165.69 | 123.49 | 207.25 | |
Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | |
Profit/Loss Before Tax | 248.48 | 165.69 | 123.49 | 207.25 | |
Tax Expenses-Continued Operations | |||||
Current Tax | 60.52 | 37.10 | 30.68 | 52.19 | |
Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | |
Deferred Tax | 0.00 | 9.48 | 2.95 | 3.25 | |
Tax For Earlier Years | 0.00 | 0.00 | 0.00 | 0.00 | |
Total Tax Expenses | 60.52 | 46.58 | 33.63 | 55.44 | |
Profit/Loss After Tax And Before ExtraOrdinary Items | 187.96 | 119.11 | 89.86 | 151.81 | |
Profit/Loss From Continuing Operations | 187.96 | 119.11 | 89.86 | 151.81 | |
Profit/Loss For The Period | 187.96 | 119.11 | 89.86 | 151.81 | |
OTHER ADDITIONAL INFORMATION | |||||
EARNINGS PER SHARE | |||||
Basic EPS (Rs.) | 23.35 | 14.80 | 11.16 | 18.86 | |
Diluted EPS (Rs.) | 23.35 | 14.80 | 11.16 | 18.86 | |
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | |||||
Imported Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | |
Indigenous Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | |
STORES, SPARES AND LOOSE TOOLS | |||||
Imported Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | |
Indigenous Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | |
DIVIDEND AND DIVIDEND PERCENTAGE | |||||
Equity Share Dividend | 0.00 | 4.83 | 4.83 | 4.39 | |
Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | |
Equity Dividend Rate (%) | 50.00 | 40.00 | 30.00 | 30.00 |
22.08.2025
03.06.2025
28.05.2025
Supriya Lifesci Standalone March 2025 Net Sales at Rs 184.11 crore, up 16.39% Y-o-Y
03.04.2025
28.05.2025
Supriya Lifesci Standalone March 2025 Net Sales at Rs 184.11 crore, up 16.39% Y-o-Y
27.01.2025
Supriya Lifesci Standalone December 2024 Net Sales at Rs 185.65 crore, up 32.54% Y-o-Y
29.10.2024
Supriya Lifesci Standalone September 2024 Net Sales at Rs 166.10 crore, up 18.56% Y-o-Y
13.08.2024
Supriya Lifesci Standalone June 2024 Net Sales at Rs 160.63 crore, up 21.67% Y-o-Y